Debate

DOI: 10.4244/EIJ-E-25-00009

Guideline recommendations for QFR should be revisited: pros and cons

William F. Fearon1, MD; Simone Biscaglia2, MD

Quantitative flow ratio (QFR) has emerged as an angiography-derived tool for the assessment of the functional significance of intermediate coronary stenoses without the need for a pressure wire or hyperaemic agent. While its diagnostic accuracy and clinical impact have been demonstrated over angiography alone, concerns remain regarding its performance compared to established invasive physiology methods, such as fractional flow reserve (FFR). In particular, recent evidence have shown a higher incidence of adverse events with QFR guidance compared to FFR guidance. In this context, the 2024 European guidelines on chronic coronary syndromes (CCS) granted a solid recommendation (Class of Recommendation I, Level of Evidence [LoE] B) for QFR in the evaluation of intermediate stenoses. However, methodological issues and conflicting findings from randomised trials are currently questioning such a strong endorsement. Whether current guideline recommendations should be revised or whether QFR should remain a first-line tool alongside FFR remains a subject of debate.

Pros

William F. Fearon, MD

Based on numerous multicentre, randomised trials and large observational registries demonstrating improved clinical outcomes in a variety of patient populations, coronary pressure wire-derived...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 21 Number 12
Jun 16, 2025
Volume 21 Number 12
View full issue


Key metrics

Suggested by Cory

Debate

10.4244/EIJ-E-24-00031 Oct 7, 2024
Quantitative flow ratio will supplant wire-based physiological indices: pros and cons
Holm NR et al
free

Editorial

10.4244/EIJ-E-25-00001 Feb 3, 2025
The pressure wire holds its ground: the debacle of QFR
Collet C et al
free

Editorial

10.4244/EIJ-E-23-00031 Aug 7, 2023
Quantitative flow ratio and cardiovascular risk: paralleling the FFR ischaemic continuum
Kern M
free

Short report

10.4244/EIJ-D-18-00955 Aug 6, 2021
Quantitative flow ratio for functional evaluation of in-stent restenosis
Liontou C et al
free

10.4244/EIJV16I4A46 Jul 17, 2020
Fractional flow reserve substitutes in aortic stenosis
Johnson NP and Tonino P
free

Clinical Research

10.4244/EIJ-D-21-00176 Feb 18, 2022
Outcomes of quantitative flow ratio-based percutaneous coronary intervention in an all-comers study
Zhang R et al
free

Clinical Research

10.4244/EIJ-D-21-00425 Feb 18, 2022
Reproducibility of quantitative flow ratio: the QREP study
Westra J et al
free
Trending articles
310.43

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
166.7

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
92.2

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
76.25

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
56.65

Clinical research

10.4244/EIJ-D-20-01155 Oct 20, 2021
A deep learning algorithm for detecting acute myocardial infarction
Liu W et al
free
35

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
33.9

CLINICAL RESEARCH

10.4244/EIJ-D-17-00381 Oct 11, 2017
Stent malapposition and the risk of stent thrombosis: mechanistic insights from an in vitro model
Foin N et al
free
33.65

State-of-the-Art

10.4244/EIJ-D-23-00606 Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved